Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
SH 03 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/18/2017
- Location: F201 + F202 (Annex Hall)
- Type: Scientific Highlights
- Track: Advanced NSCLC
-
+
SH 03.01 - Advanced NSCLC and Immunology and Immunotherapy
07:00 - 07:20 | Presenter: Nico Van Zandwijk
- Abstract
No abstract available for this presentation
-
+
SH 03.02 - Early Stage NSCLC and Radiology/Staging/Screening
07:20 - 07:40 | Presenter: Jaroslaw Kuzdzal
- Abstract
No abstract available for this presentation
-
+
SH 03.03 - Biology/Pathology and Epidemiology/Primary Prevention/Tobacco Control and Cessation
07:40 - 08:00 | Presenter: Anja C Roden
- Abstract
No abstract available for this presentation
-
+
SH 04 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/18/2017
- Location: F203 + F204 (Annex Hall)
- Type: Scientific Highlights
- Track: Biology/Pathology
-
+
SH 04.01 - Chemotherapy/Targeted Therapy, Nursing/Palliative Care/Ethics and SCLC/Neuroendocrine Tumors
07:00 - 07:20 | Presenter: Paul Baas
- Abstract
No abstract available for this presentation
-
+
SH 04.02 - Locally Advanced NSCLC & Radiotherapy
07:20 - 07:40 | Presenter: Fumihiro Tanaka
- Abstract
No abstract available for this presentation
-
+
SH 04.03 - Biology/Pathology and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
07:40 - 08:00 | Presenter: Kenzo Hiroshima
- Abstract
No abstract available for this presentation
-
+
Communication Skills Workshop (not public)
- 08:00 - 14:00
- 10/18/2017
- Location: Room 317
- Type: Workshop
- Track:
-
+
Communication Techniques
08:00 - 08:40 | Presenter: J. Carter
- Abstract
No abstract available for this presentation
-
+
PL 03 - Immunology in Lung Cancer Update 2017
- 08:15 - 09:45
- 10/18/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Immunology and Immunotherapy
- Moderators:David P Carbone, Keunchil Park
-
+
PL 03.01 - Serendipities of Acquired Immunity
08:15 - 08:45 | Presenter: Tasuku Honjo
- Abstract
Loading... -
+
PL 03.02 - Biomarkers in Immunooncology Therapy
08:45 - 09:05 | Presenter: Naiyer Rizvi
- Abstract
No abstract available for this presentation
-
+
PL 03.03 - Blueprint 2: PD-L1 Immunohistochemistry Comparability Study in Real-Life, Clinical Samples
09:05 - 09:25 | Presenter: Ming Sound Tsao | Author(s): Keith M Kerr, Yasushi Yatabe, Fred R. Hirsch
- Abstract
Loading... -
+
PL 03.04 - Current Status and Future of Immunotherapy in Lung Cancer
09:25 - 09:45 | Presenter: Martin Reck
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-001 - Comparisons of Two Plasma EGFR Platforms (ddPCR and Cobas) in Patients with Radiological Metastatic Lung Cancer
09:30 - 09:30 | Presenter: Jacky Yu Chung Li | Author(s): K. Wan, W.H. Lau, W. Cheuk
- Abstract
Loading... -
+
P3.01-002 - Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient with EGFR TKI Drug Resistance
09:30 - 09:30 | Presenter: Renwang Liu | Author(s): S. Xu, X. Liu, T. Shi, Xiongfei Li, D. Zhong, Y. Wang, G. Chen, J. Chen
- Abstract
Loading... -
+
P3.01-003 - Study of the Relationship between EGFR Mutation Status and Bone Metastasis in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Zhao Bing | Author(s): A. Xiaoye, A. Yasheng
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-005 - ASTRIS: A Real World Study of Osimertinib Treatment in Patients with EGFR T790M Positive Advanced NSCLC; Interim Analysis
09:30 - 09:30 | Presenter: Sang-We Kim | Author(s): Byoung Chul Cho, D. Kim, Keunchil Park, M. Tiseo, M.R. Migliorino, A. Santo, J. Lee, D. Vicente, A. Paredes, E. O'Hanrahan, Helano Carioca Freitas, M. Provencio, Y. Chen, P.K. Cheema, A. Milner, J.R. Rigas, Yi-Long Wu, F. De Marinis
- Abstract
Loading... -
+
P3.01-006 - Osimertinib in Pretreated EGFR T790M-Positive Non-Small Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
09:30 - 09:30 | Presenter: Bin-Chi Liao | Author(s): Chia-Chi Lin, J. Lee, C. Ho, K. Chen, Y. Chen, H. Lien, J. Shih, C. Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
P3.01-007 - Heterogeneous Resistance Mechanisms in Rebiopsies from EGFR-Mutated NSCLC: Transformation to SCLC; FGFR3 and T790M Mutations
09:30 - 09:30 | Presenter: Edyta Maria Urbanska | Author(s): M. Grauslund, L.C. Melchior, J.B. Sørensen, E. Santoni-Rugiu
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-009 - Clinical Efficacy of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 18 E709X Mutations
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Rongrong Chen, Y. Guan, Gang Chen, X. Yi, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.01-010 - High Probability and Frequency of EGFR Mutations in Non-Small Cell Lung Cancer with Brain Metastases
09:30 - 09:30 | Presenter: Xiaohua Liang | Author(s): M. Ge, Q. Zhan, R. Huang, X. Zhou
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-012 - Symptom Impact of First-Line Dacomitinib versus Gefitinib in EGFR-Positive NSCLC: Results from a Randomized Phase 3 Study
09:30 - 09:30 | Presenter: Rickard Sandin | Author(s): M.R. Migliorino, Tony SK Mok, Yi-Long Wu, X. Zhou, K.H. Lee, Kazuhiko Nakagawa, Seiji Niho, F. Tsuji, R. Linke, Rafael Rosell, J. Corral, A. Pluzanski, E.I. Sbar, A. Reisman, T. Wang, J.L. White, Ying Cheng
- Abstract
Loading... -
+
P3.01-013 - CNS Metastases in EGFR Mutation Positive NSCLC: Impact on Health Resource Utilization
09:30 - 09:30 | Presenter: Negar Chooback | Author(s): S. Lefresne, Sally C Lau, C. Ho
- Abstract
Loading... -
+
P3.01-015 - Differential Outcomes between First and Second Generation TKIs in Patients with Activating EGFR Mutations in NSCLC
09:30 - 09:30 | Presenter: Sally C Lau | Author(s): Negar Chooback, C. Ho, Barbara Melosky
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-017 - Clinical Outcomes of Patients with EGFR T790M + NSCLC on Osimertinib
09:30 - 09:30 | Presenter: Wan Ling Tan | Author(s): T.P. Hennedige, Q.S. Ng, S.H. Tan, N.T.A. Tran, B.J.G. Chua, C.K. Toh, E.H. Tan, Daniel SW Tan, M. Ang, R. Kanesvaran, A. Jain, T.K.H. Lim, A. Gogna, M. Koh, C.S.P. Yip, C.H. Thng, B. Chowbay, M.H. Tan, Wan-Teck Lim
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-019 - Canadian Multicentre Validation Study of Plasma Circulating Tumour DNA for Epidermal Growth Factor (EGFR) T790M Testing
09:30 - 09:30 | Presenter: Ming Sound Tsao | Author(s): T. Zhang, P.K. Cheema, J. Laskin, A. Karsan, T. Barnes, G. Liu, S. Owen, J. Rothenstein, R. Burkes, M. Iqbal, A. Spatz, I. Izevbaye, L.V. Kempen, S. Kamel-Reid, Natasha B Leighl
- Abstract
Loading... -
+
P3.01-020 - Clinical Features of Patients with Non-Small Cell Lung Cancer (NSCLC) Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations in Brunei
09:30 - 09:30 | Presenter: Shir Kiong Lu | Author(s): C.H. Leong, S. Binti Hj Mohd Diah, R.S. Patnaik, B. Sukumaran
- Abstract
Loading... -
+
P3.01-021 - A Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients with IIIB/IV NSCLC in Northern China
09:30 - 09:30 | Presenter: Ying Cheng | Author(s): Y. Wang, J. Zhao, Y. Liu, H. Gao, K. Ma, S. Zhang, H. Xin, J. Liu, C. Han, Z. Zhu, Y. Wang, Jun Chen, F. Wen, J. Li, J. Zhang, Z. Zheng, Z. Dai, H. Piao, X. Li, Y. Li, M. Zhong, R. Ma, Y. Zhuang, Y. Xu, Z. Qu, H. Yang, C. Pan, F. Yang, D. Zhang, B. Li
- Abstract
Loading... -
+
P3.01-022 - Prognostic Value of Clinical, Immune and Biochemical Markers in EGFR-Mutant NSCLC Patients Treated with First-Line EGFR TKIs
09:30 - 09:30 | Presenter: Isaac Kah Siang Ng | Author(s): N.B. Kumarakulasinghe, N. Syn, R.S.Y. Teng, R. Soo
- Abstract
Loading... -
+
P3.01-023 - First-line Afatinib for Non-Small Cell Lung Cancer in Real World Practice
09:30 - 09:30 | Presenter: Youjin Kim | Author(s): Jong-Mu Sun, Keunchil Park, Song Ee Park, S. Lee, Myung-Ju Ahn, Jin Seok Ahn, S.W. Lim, H. Lee, J.H. Cho, H.K. Kim
- Abstract
Loading... -
+
P3.01-024 - Characterization of PD-L1 Expression and Its Predictive and Prognostic Significance in EGFR-Mutant NSCLC Patients Treated with EGFR-TKIs
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): Caicun Zhou
- Abstract
Loading... -
+
P3.01-025 - Treatment Outcomes of Advanced Lung Adenocarcinoma with Unknown EGFR Gene Status: A Retrospective Analysis of 140 Patients
09:30 - 09:30 | Presenter: Cheng Xiao | Author(s): L.Y. Zheng, C. Mao, H. Jiang, J. Qian, N. Xu
- Abstract
Loading... -
+
P3.01-026 - Analysis of Long-Term Response to First-Line Afatinib in the LUX-Lung 3, 6 and 7 Trials in Advanced EGFRm+ NSCLC
09:30 - 09:30 | Presenter: Martin Schuler | Author(s): James Chih-Hsin Yang, Lecia V Sequist, Yi-Long Wu, Caicun Zhou, S.L. Geater, Tony SK Mok, E. Tan, C. Hu, Nobuyuki Yamamoto, J. Feng, Kenneth Obyrne, Shun Lu, Vera Hirsh, Y. Huang, S. Ellis, C. Samuelsen, A. Märten, J. Fan, Keunchil Park, Luis Paz-Ares
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-028 - Efficacy of Osimertinib for Brain Metastasis in Advanced NSCLC: Data from Single Center in ASTRIS Trial
09:30 - 09:30 | Presenter: Jee Hung Kim | Author(s): Hye Ryun Kim, Min Hee Hong, I.Y. Bang, R. Kim, H.W. Jung, H.J. Cho, H. Kim, H. Kim, Byoung Chul Cho
- Abstract
Loading... -
+
P3.01-029 - Transient Asymptomatic Pulmonary Opacities (TAPOs) during Osimertinib Treatment and Its Clinical Implication
09:30 - 09:30 | Presenter: Hansang Lee | Author(s): H. Lee, Jong-Mu Sun, S. Lee, Youjin Kim, Song Ee Park, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P3.01-030 - CNS Metastases in EGFR Mutation Positive (EGFRm) NSCLC Patients: The Prognostic Relevance of Presenting Symptoms
09:30 - 09:30 | Presenter: Negar Chooback | Author(s): Sally C Lau, S. Lefresne, C. Ho
- Abstract
Loading... -
+
P3.01-031 - ctDNA Assessment of EGFR Mutation Status in Chinese Patients with Advanced Non–Small-Cell Lung Cancer in Read World Setting
09:30 - 09:30 | Presenter: Shirong Zhang | Author(s): Lucheng Zhu, Xueqin Chen, E. Chen, Y. Li, H. Fang, Y. Feng, Z. Qiong, H. He, Shenglin Ma
- Abstract
Loading... -
+
P3.01-032 - Preliminary study of Lung Cancer Adenocarcinoma with De-novo EGFR T790M Mutation in Persahabatan Hospital-Jakarta, Indonesia.
09:30 - 09:30 | Presenter: Hapsari Dewanti | Author(s): Jamal Zaini, Sita Andarini, Elisna Syahruddin, A.C. Putra, A. Hudoyo
- Abstract
Loading... -
+
P3.01-033 - Detection of Epidermal Growth Factor Receptor Mutations with Plasma Sample Compared with Tumor Tissue Biopsy in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Taewon Jang | Author(s): C. Oak, M. Jung
- Abstract
Loading... -
+
P3.01-034 - Liquid Biopsy for EGFR Genotyping Using Cell-Free DNA and Extracellular Vesicular DNA of Pleural Effusion in Pulmonary Adenocarcinoma Patients
09:30 - 09:30 | Presenter: Jong Sik Lee | Author(s): J.Y. Hur, In Ae Kim, H.J. Kim, C. Choi, Jae Cheol Lee, W.S. Kim, K.Y. Lee
- Abstract
Loading... -
+
P3.01-035 - Post-Marketing Observational Study of Japanese Patients with EGFR Mutation-Positive (EGFRm+) NSCLC Treated with Daily Afatinib (Final Report)
09:30 - 09:30 | Presenter: Nobuyuki Yamamoto | Author(s): T. Nukiwa, Yoichi Nakanishi, Akihiko Gemma, M. Mizushima, T. Takayama, J. Kumazawa, H. Azuma, K. Tamura
- Abstract
Loading... -
+
P3.01-036 - A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): H. Tu, J. Feng, M. Shi, J. Zhao, Y. Wang, J. Chang, J. Wang, Ying Cheng, J. Zhu, E. Tan, K. Li, Y. Zhang, V. Lee, C. Yang, W. Su, C.L. Lam, B. Srinivasa, S. Rajappa, C. Ho, K.C. Lam, Y. Hu, S.A. Bondarde, X. Liu, J. Fan, D. Kuo, Y. Wang, K. Pang, Caicun Zhou
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-038 - Impact on OS and PFS of 2nd and 3rd Generation TKI in EGFR Mt+ and ALK+ Patients: Results of the NOWEL Network
09:30 - 09:30 | Presenter: Julia Roeper | Author(s): M. Netchaeva, A.C. Lueers, C. Hallas, M. Falk, M. Tiemann, N. Neemann, L.C. Heukamp, C. Wesseler, G. Wiest, S. Sackmann, D. Ukena, Frank Griesinger
- Abstract
Loading... -
+
P3.01-040 - Real-World Management of Patients with EGFR Mutation-Positive NSCLC in the US
09:30 - 09:30 | Presenter: Apar Kishor Ganti | Author(s): Y. Li, A. Appius, T. Pattipaka, A. Feyereislova, A. Cassidy
- Abstract
Loading... -
+
P3.01-041 - The Robustness of Allele-Specific qPCR Assays for Detection of EGFR Mutations in Plasma Cell-Free DNA from NSCLC Patients
09:30 - 09:30 | Presenter: Joanna Chorostowska-Wynimko | Author(s): A. Szpechcinski, K. Duk, P. Wojcik, W. Kupis, Piotr Rudzinski, M. Bryl, G. Czyzewicz, T. Orlowski
- Abstract
Loading... -
+
P3.01-042 - Efficacy & Tolerability of Afatinib in NSCLC Patients Prior Exposure to 1st Generation EGFR TKI: Thailand Multicenter Study
09:30 - 09:30 | Presenter: Thanyanan Reungwetwattana | Author(s): S. Laohavinij, W. Lamlertthon, B. Chewaskulyong, A. Dechaphunkul, S. Detarkom, D. Muntham, N. Poovorawan, V. Srimuninnimit, V. Sriuranpong
- Abstract
Loading... -
+
P3.01-043 - Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung
09:30 - 09:30 | Presenter: Shirish M Gadgeel | Author(s): Glenwood Goss, Enriqueta Felip, M. Cobo, Shun Lu, K. Syrigos, K.H. Lee, E. Göker, V. Georgoulias, W. Li, S. Guclu, D. Isla, Y. Joo Min, A. Morabito, A. Ardizzoni, N. Gibson, N. Krämer, F. Solca, A. Cseh, E. Ehrnrooth, J. Soria
- Abstract
Loading... -
+
P3.01-044 - Erlotinib vs Chemotherapy in EGFR Mut+ NSCLC: OS in Three Phase III Trials Adjusting for Post-Progression Treatment Crossover
09:30 - 09:30 | Presenter: Yi-Long Wu | Author(s): Caicun Zhou, M. Truman, A. Feyereislova, R. Rossell
- Abstract
Loading... -
+
P3.01-045 - Correlation of EGFR Mutation Detection in CtDNA by Two Different Platforms in Advanced NSCLC Patients from a Single Institution
09:30 - 09:30 | Presenter: Noemi Reguart | Author(s): N. Vilariño, J.A. Puig-Butille, R. Reyes, I. Victoria, A. Arcocha, P. Jares, N. Viñolas, J.M. González De Aledo, Rafael Molina, C. Teixido, A. Prat
- Abstract
Loading... -
+
P3.01-046 - Longitudinal Analysis of Plasma CtDNA in EGFR-Mutant NSCLC: SWOG S1403 Trial of Afatinib with or Without Cetuximab
09:30 - 09:30 | Presenter: Philip Christopher Mack | Author(s): J. Miao, K.C. Banks, R.A. Burich, K. Politi, V.M. Raymond, D. Dix, R.B. Lanman, J. Moon, M.A.C. Melnick, A. Truini, Mary Redman, S.B. Goldberg, David R. Gandara, Karen Kelly
- Abstract
Loading... -
+
P3.01-047 - Erlotinib Induced Ectropion Followed by Papulo-Erythemato Skin Rash
09:30 - 09:30 | Presenter: Abdolali Shahrasbi
- Abstract
Loading... -
+
P3.01-048 - CBL Mutations as Potential Mediators of EGFR TKI Resistance Effectively Treated with Sitravatinib
09:30 - 09:30 | Presenter: Lyudmila A Bazhenova | Author(s): S.T. Neuteboom, I. Chen, R.C. Chao, J.G. Christensen
- Abstract
Loading... -
+
P3.01-049 - T790M Mutation Detection, Clinical Characteristics and Impact in NSCLC Patients Treated with EGFR Tyrosine Kinase Inhibitors
09:30 - 09:30 | Presenter: Júlio Oliveira | Author(s): L. Bei, M. Pinheiro, I. Veiga, A. Peixoto, P. Rocha, C. Oliveira, A. Rodrigues, I. Pousa, I. Azevedo, R. Henrique, M.R. Teixeira, M. Soares
- Abstract
Loading... -
+
P3.01-050 - A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis
09:30 - 09:30 | Presenter: Byoung Chul Cho | Author(s): D. Kim, Keunchil Park, J. Lee, S.S. Yoo, Jin-Hyoung Kang, Sung Yong Lee, C.H. Kim, S.H. Jang, Young-Chul Kim, H. Yoon, Sang-We Kim
- Abstract
Loading... -
+
P3.01-051 - Dramatic Response to Afatinib in EGFR-Mutant Lung Adenocarcinomas After Resistance to First-Generation EGFR Inhibitors: A Brief Report
09:30 - 09:30 | Presenter: Wen -Feng Li | Author(s): Jin -Ji Yang, H.-. Chen, A.-. Li, J.-. Lin, H.-. Tu, J. Su, X.-. Zhang, Yi-Long Wu
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-053 - Detection of Common EGFR Mutation in Cytological Smears Using Reversed Dot Blot (RDB) Hybridization Method
09:30 - 09:30 | Presenter: Najmiatul Masykura | Author(s): D.A. Kwang, Jamal Zaini, Sita Andarini, A. Hudoyo, Elisna Syahruddin, M. Levi, G. Widjajahakim, A.R.H. Utomo
- Abstract
Loading... -
+
P3.01-054 - Urinary ct-DNA Testing of EGFR Common Mutation in Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Asep Muhamad Ridwanuloh | Author(s): H. Hariyatun, F.P. Patria, A. Hudoyo, Jamal Zaini, Sita Andarini, Najmiatul Masykura, A.R.H. Utomo
- Abstract
Loading... -
+
P3.01-055 - The Usefulness of Liquid Biopsy for ctDNA in Patients with EGFR-Mutant NSCLC During and After Treatment with EGFR-TKIs
09:30 - 09:30 | Presenter: Takuma Yokoyama | Author(s): G. Naka, H. Ishida, K. Kishi, Y. Ohashi, Hideo Kunitoh
- Abstract
Loading... -
+
P3.01-056 - Intracranial Activity of Osimertinib in Naïve EGFRm T790M(-)And Treated EGFRm T790M(+) NSCLC Patients with Asymptomatic Brain Metastases
09:30 - 09:30 | Presenter: Nir Peled | Author(s): H. Nechushtan, M. Ilouze, Elizabeth Dudnik, E. Inbar
- Abstract
Loading... -
+
P3.01-057 - Comparison of EGFR Mutations in Matched Tumor Tissues, Cell Blocks, Pleural Effusions and Bloods with NSCLC, by PANA Mutyper and PNA Clamping
09:30 - 09:30 | Presenter: Seung Joon Kim | Author(s): Chan Kwon Park, Y.K. Kim
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-059 - First Experience with Osimertinib in Patients with Newly Developed T790M Mutation Previously Treated with EGFR – TKIs in Croatia
09:30 - 09:30 | Presenter: Marko Jakopovic | Author(s): L. Bitar, F. Seiwerth, S. Plestina, S. Kukulj, S. Seiwerth, M. Misic, G. Redzepi, M. Samarzija
- Abstract
Loading... -
+
P3.01-060 - The Clinical Utility of ctDNA Gene Analysis in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): A. Belilovski Rozenblum, M. Ilouze, L.C. Roisman, Elizabeth Dudnik, A. Zer, T. Twito, A. Dvir, L. Soussan-Gutman, R.B. Lanman, Nir Peled
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-062 - The Perceived Value of Avoiding Biopsy: Patients' Willingness to Pay for Circulating Tumour DNA T790M Testing
09:30 - 09:30 | Presenter: Tristan Alexandra Barnes | Author(s): J. Laskin, P.K. Cheema, G. Liu, M. Iqbal, J. Rothenstein, R. Burkes, S. Owen, D. Laurence, I. Carvalhana, L. Markin, L. Wong, N. Perera-Low, M. Sawczak, Ming Sound Tsao, Natasha B Leighl
- Abstract
Loading... -
+
P3.01-063 - Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Rui-Lian Chen | Author(s): X. Zhang, Yi-Long Wu, H. Chen, Qing Zhou, J. Su, H. Tu, Z. Xie, W. Zhong, Jin -Ji Yang
- Abstract
Loading... -
+
P3.01-064 - Detection of EGFR Mutations in Circulating Tumor DNA Using Plasma Samples: Clinical Validation of Cobas EGFR Mutation Test V2
09:30 - 09:30 | Presenter: Hidetoshi Itani | Author(s): K. Iwamoto, Y. Ito, H. Sasano, S. Kondo, M. Tanigawa
- Abstract
Loading... -
+
P3.01-065 - Advanced NSCLC with EGFR Mutations in Elderly Patients. Single-Centre Experience
09:30 - 09:30 | Presenter: Angel Artal Cortes | Author(s): I. Torres, M. Álvarez, A. Comin, P. Felices, A. Nuño, I. Gurruchaga, D. Márquez, A. Viñaras, J. Hernando
- Abstract
Loading... -
+
P3.01-066 - CNS Metastases of Pulmonary Adenocarcinoma Harboring EGFR-Activating Mutations: a Multidisciplinary Approach, Including EGFR-TKis
09:30 - 09:30 | Presenter: Renata Rodrigues da Cunha Colombo Bonadio | Author(s): G. Harada, G.N. Marta, T.K. Takahashi, T. Takagaki, G. De Castro Jr
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-068 - Investigation of Low Plasma/Tissue EGFR Concordance in Russia: Follow-up to the IGNITE Global Diagnostic Study
09:30 - 09:30 | Presenter: Brian B Lentrichia | Author(s): H. Brown, M. Ratcliffe, A.M. Rachiglio, R. Pasquale, N. Normanno
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-071 - Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa | Author(s): Edward Brian Garon, Luis Paz-Ares, S. Ponce, J. Corral Jaime, O. Juan Vidal, Ernest Nadal, K. Kiura, Keunchil Park, R.C. Widau, E. Alexandris, S. He, P. Lee, Martin Reck
- Abstract
Loading... -
+
P3.01-072 - Dacomitinib Versus Gefitinib for First-Line Treatment of Advanced EGFR+ NSCLC in Japanese Patients (ARCHER 1050)
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa | Author(s): F. Ohyanagi, Terufumi Kato, T. Takahashi, H. Kaneda, N. Nogami, Seiji Niho, N. Yamamoto, Y. Fujita, H. Zhang, E.I. Sbar, T. Wang, R. Linke, F. Tsuji, Tony SK Mok
- Abstract
Loading... -
+
P3.01-073 - TPX-0005 with an EGFR Tyrosine Kinase Inhibitor (TKI) Overcomes Innate Resistance in EGFR Mutant NSCLC
09:30 - 09:30 | Presenter: Rafael Rosell | Author(s): Niki Karachaliou, J. Jean Cui, I. Chaib, J. Berenguer, J. Bratch, X. Li, J. Yang, A. Drozdowskyj, C. Codony Servat, J. Codony Servat, A. Giménez-Capitán, S. Viteri, Miguel-Angel Molina-Vila, G. López-Vivanco, A. Vergnenegre, José Miguel Sánchez-Torres, M. Provencio, F. De Marinis, A. Passaro, Enric Carcereny, Noemi Reguart, Rosario García Campelo, S. Ignatius Ou, Andrés F. Cardona, P. Cao
- Abstract
Loading... -
+
P3.01-074 - Genomic Analysis of Tumor and Plasma in T790M Mutant Positive EGFR Lung Cancer Patients before and after Osimertinib Treatment
09:30 - 09:30 | Presenter: James Chih-Hsin Yang | Author(s): C. Yu, J. Shih, C. Ho, W. Liao, J. Lee, T. Tsai, K. Su, M. Shih, Y.L. Chang, Y. Bai, D. Huang, K.S. Thress, Chia-Chi Lin
- Abstract
Loading... -
+
P3.01-075 - Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC
09:30 - 09:30 | Presenter: Vera Hirsh | Author(s): E. Tan, Yi-Long Wu, Lecia V Sequist, Caicun Zhou, Martin Schuler, S.L. Geater, Tony SK Mok, C. Hu, Nobuyuki Yamamoto, J. Feng, Kenneth Obyrne, Shun Lu, Y. Huang, M. Sebastian, Isamu Okamoto, N. Dickgreber, R. Shah, M. Palmer, A. Märten, D. Massey, C. Samuelsen, James Chih-Hsin Yang
- Abstract
Loading... -
+
P3.01-076 - QTWiST Analysis to Compare the Benefit of Gefitinib Versus Pemetrexed Platinum for Patients with EGFR Mutated NSCLC
09:30 - 09:30 | Presenter: Vijay Patil | Author(s): V. Noronha, A. Joshi, Alok Goel, Vikas Talreja, A. Kapoor, R. Kumar, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading... -
+
P3.01-076a - Lung Cancer Stem Cell (LCSC) Markers and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Resistance
09:30 - 09:30 | Presenter: Shinnosuke Takemoto
- Abstract
No abstract available for this presentation
-
+
P3.01-077 - Effectiveness of Methylnaltrexone Bromide in Opioid-Induced Constipation in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Ioannis Dimitroulis | Author(s): P. Peristeris, M. Toumbis
- Abstract
Loading... -
+
P3.01-079 - Evaluating the Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients with Stage IIIa (N2) Lung Cancer
09:30 - 09:30 | Presenter: Luo-Sheng Yong | Author(s): S. Kuo, P. Huang, Mong-Wei Lin, Ke-Cheng Chen, J. Lee
- Abstract
Loading... -
+
P3.01-080 - Overall Survival (OS) of Pathological N2 Non-Small Cell Lung Cancer (NSCLC) After Surgical Resection
09:30 - 09:30 | Presenter: Etienne Bourdages-Pageau | Author(s): Arthur Vieira, C. Labbé, P.A. Ugalde Figueroa
- Abstract
Loading... -
+
P3.01-081 - Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging
09:30 - 09:30 | Presenter: Arthur Vieira | Author(s): Etienne Bourdages-Pageau, C. Labbé, P.A. Ugalde Figueroa
- Abstract
Loading... -
+
P3.01-082 - Surgical Rebiopsy in Advanced Non-Small Cell Lung Cancer Resistant to Previous Chemotherapy
09:30 - 09:30 | Presenter: Sumin Shin | Author(s): Jong Ho Cho, Hong Kwan Kim, Y.S. Choi, Jhingook Kim, J.I. Zo, Keunchil Park, Myung-Ju Ahn, Jin Seok Ahn, Jong-Mu Sun, S. Lee, Y.M. Shim
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-084 - Analysis on ALTER0303 Trial: aCECs Level May Correlate with Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC
09:30 - 09:30 | Presenter: Kai Li | Author(s): Z. Liu, J. Wang, Z. Meng, X. Wang, C. Zhang, J. Chen, X. Jiang, L. Wang, L. Lin, X. Zhang, P. Chen, C. Huang, R. Jiang
- Abstract
Loading... -
+
P3.01-085 - A Phase 2 Trial of Apatinib in Advanced Non-Squamous NSCLC: Updated Data and Clinical Benefit of Continuing Apatinib after Initial Progression
09:30 - 09:30 | Presenter: Fengying Wu | Author(s): S. Zhang, J. Yu, G. Gao, W. Li, Weijing Cai, C. Su, X. Chen, S. Ren, Caicun Zhou
- Abstract
Loading... -
+
P3.01-086 - Biomarker Testing Trends and Treatment Patterns in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients in the United States
09:30 - 09:30 | Presenter: Laura Chu | Author(s): F.A. Corvino, J. Yi, M. Zivkovic, W. Wong
- Abstract
Loading... -
+
P3.01-087 - Impact Factor Analysis for Efficacy and Prognosis of Anlotinib in NSCLC as Third-Line Treatment: Data from Trial ALTER 0303
09:30 - 09:30 | Presenter: Kai Li | Author(s): J. Wang, Baohui Han, Y.Z. Zhao, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, J. Dong, B. Li, Y. Chen, J. Zhou, D. Wang, X. Zhou, Y. Yu, L. Chen, A. Liu, J. Huang, C. Huang, B. Cao, J. Chen, R. Ma, Z. Yu, C. Ding, H. Wang
- Abstract
Loading... -
+
P3.01-088 - Molecular Testing and First-Line Treatment of Patients with NSCLC. First Results from the German CRISP Study (AIO-TRK-0315)
09:30 - 09:30 | Presenter: M. Sebastian | Author(s): Frank Griesinger, Wilfried Eberhardt, A. Nusch, M. Reiser, C. Losem, S. Ketzler-Henkel, M. Zahn, N. Marschner, M. Jänicke, A. Fleitz, L. Spring, J. Sahlmann, A. Karatas, A. Hipper, M. De Wit, M. Metzenmacher, C. Waller, J. Kern, W. Weichert, M. Thomas
- Abstract
Loading... -
+
P3.01-088a - Phase II Study of Nab-Paclitaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: SNIPER Study
09:30 - 09:30 | Presenter: Naruo Yoshimura | Author(s): S. Kudoh, Y. Matsumoto, K. Sawa, N. Yoshimoto, Tomohiro Suzumura, K. Tanaka, S. Mitsuoka, Tatsuo Kimura, T. Yana, Tomoya Kawaguchi, K. Hirata
- Abstract
Loading... -
+
P3.01-088b - Is Efficacy Result in Phase 2 Trial Replicated in Phase 3 Trial in Advanced NSCLC: A Meta-Analysis
09:30 - 09:30 | Presenter: R. Shibaki | Author(s): H. Akamatsu, K. Mori, S. Teraoka, K. Kanai, A. Hayata, N. Tokudome, K. Akamatsu, Y. Koh, H. Ueda, M. Nakanishi, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P3.01-088c - Exosomal Amphiregulin Induce Osteoclastogenesis Through Osteoclast Differentiation Mediated by EGFR Pathway
09:30 - 09:30 | Presenter: Christian Rolfo | Author(s): S. Taverna, M. Pucci, M. Giallombardo, M. Antonietta De Bella, P. Reclusa, Ignacio Gil-Bazo, R. Alessandro
- Abstract
Loading... -
+
P3.01-088d - TTFields Combined with PD-1 Inhibitors or Docetaxel for 2nd Line Treatment of Non-Small-Cell Lung Cancer (NSCLC): Phase 3 LUNAR Study
09:30 - 09:30 | Presenter: Uri Weinberg | Author(s): O. Farber, Moshe Giladi, Zeev Bomzon, E. Kirson
- Abstract
Loading... -
+
P3.01-088e - TTFields Delivery to the Brain: An Overview of Computational Studies and Implications When Treating Brain Metastases
09:30 - 09:30 | Presenter: Uri Weinberg | Author(s): S. Levi, Zeev Bomzon, A. Naveh, E. Kirson
- Abstract
Loading... -
+
P3.01-088f - Droplet Digital PCR-Based EGFR Mutation Detection with an Internal Quality Control Index to Determine the Quality of DNA
09:30 - 09:30 | Presenter: Sung Su Kim | Author(s): H. Choi, J.J. Kim, M.S. Kim, I. Lee, B. Byun, L. Jia, M.R. Oh, Y. Moon, S. Park, J. Choi, S.W. Chae, B. Nam, J. Kim, J. Kim, B.S. Min, J.S. Lee, J. Won, S.Y. Cho, Yoon-La Choi, Y.K. Shin
- Abstract
Loading... -
+
P3.01-088g - Variation in Treatment Recommendations for NSCLC Patients by Multidisciplinary Tumor Board Meetings Across the Netherlands
09:30 - 09:30 | Presenter: Margriet Kwint | Author(s): O. Candiff, J. Belderbos, P. Berkhout, R. Damhuis, Egbert F Smit, Iris Walraven
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.01-088i - Phase Ib Trial of Xentuzumab and Abemaciclib in Advanced or Metastatic Solid Tumors, including Advanced NSCLC
09:30 - 09:30 | Presenter: D. Portsmouth | Author(s): Douglas Yee, A. Prat, M.P. Sablin, H. Iwata, E.L. Johnston, T. Bogenrieder, J. Serra, H. Hua, P. Lo Russo
- Abstract
Loading... -
+
P3.01-088j - The Transitions of Prognostic Understanding and Its Associated Factors in Japanese Patients with Advanced Lung Cancer and Their Caregivers
09:30 - 09:30 | Presenter: Daisuke Arai | Author(s): I. Nakachi, K. Soejima, M. Takeuchi, D. Fujisawa, T. Sato, K. Naoki, I. Kawada, H. Yasuda, K. Kobayashi, S. Nukaga, K. Masaki, T. Inoue, K. Hikima, M. Nakamura, Kota Ishioka, Y. Oyamada, Y. Funatsu, T. Terashima, N. Miyao, K. Sayama, O. Keiko, F. Sakamaki, F. Saito, T. Betsuyaku
- Abstract
Loading... -
+
P3.01-088k - Significance of Second Rebiopsy for Detecting T790M Mutation
09:30 - 09:30 | Presenter: Eiki Ichihara | Author(s): K. Hotta, T. Higashionna, T. Ninomiya, T. Kubo, K. Ohashi, M. Tabata, K. Kiura
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
- Abstract
Loading... -
+
P3.02-002 - Liquid and Solid Rebiopsies in EGFR-Mutated NSCLC Patients
09:30 - 09:30 | Presenter: Alexis B Cortot | Author(s): D. Nunes, E. Dansin, C. Lamblin, E. Wasielewski, C. Descarpentries, V. Grégoire, M.C. Copin, F. Escande
- Abstract
Loading... -
+
P3.02-003 - Tissue and Serum Levels of Galectin-3 in NSCLC Patients
09:30 - 09:30 | Presenter: Yoko Kataoka | Author(s): Y. Ohshio, Tomoyuki Igarashi, Koji Teramoto, J. Hanaoka
- Abstract
Loading... -
+
P3.02-004 - Analysis of MET in Liquid Biopsy and Tissue Biopsy in Patients with Advanced NSCLC: Incidence and Pattern.
09:30 - 09:30 | Presenter: Edgardo S. Santos | Author(s): L.D.C. Castillero
- Abstract
Loading... -
+
P3.02-005 - Applicability of Ion Torrent Colon and Lung Sequencing Panel on Circulating Cell-Free DNA
09:30 - 09:30 | Presenter: Christina Demuth | Author(s): Anne Tranberg Madsen, A. Winther-Larsen, P. Meldgaard, B.S. Sørensen
- Abstract
Loading... -
+
P3.02-006 - Monitoring Genetic Alterations in Plasma during Anti-Cancer Treatment in Advanced NSCLC (MAGIC1-Validation Cohort: Preliminary Results)
09:30 - 09:30 | Presenter: Laura Bonanno | Author(s): I. Attili, E. Zulato, G. Nardo, M. Verza, A. Pavan, P. Del Bianco, G. Pasello, G. Zago, V. Polo, S. Frega, N. Milite, M.C. Carlucci, F. Calabrese, G.L. De Salvo, P. Conte, S. Indraccolo
- Abstract
Loading... -
+
P3.02-007 - Circulating miRNAs as Prognostic Biomarkers in Resected Early-Stages Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Lucio Crinò | Author(s): P. Ulivi, E. Petracci, V. Ludovini, G. Marisi, S. Baglivo, R. Chiari, A. Delmonte, N. De Luigi, D. Amadori, F. Grignani
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-009 - Mutation Detection in Cell-Free DNA from Patients with Lung Adenocarcinoma by Next-Generation Sequencing
09:30 - 09:30 | Presenter: Hana Khairina Putri Faisal | Author(s): S. Hirano, F. Irisuna, S. Kimura, N. Morihara, T. Fukazawa, A. Arfan, Y. Horimasu, N. Hattori, N. Kohno, E. Hiyama
- Abstract
Loading... -
+
P3.02-010 - Significant Increase of Blood Extracellular Vesicles in Pulmonary Vein as Potential Prognostic Biomarker for Lung Cancer Patients
09:30 - 09:30 | Presenter: Byeon Hyeon Choi | Author(s): Yu Hua Quan, Jiyun Rho, R. Xu, Y. Choi, J. Park, Y.B. Choy, Y.H. Choi, H.K. Kim
- Abstract
Loading... -
+
P3.02-011 - A Prospective Study of Serial Circulating Tumor DNA Assessment in Detecting Recurrence of Resected Early-stage Lung Cancer
09:30 - 09:30 | Presenter: Hong Kwan Kim | Author(s): Jong Ho Cho, S. Lee, J. Lee, Y.S. Choi, J.I. Zo, Y.M. Shim, S. Mortimer, J. Odegaard, Jhingook Kim
- Abstract
Loading... -
+
P3.02-012 - Liquid Based Cytology (LBC) Specimens Were Useful for EGFR Mutation Test
09:30 - 09:30 | Presenter: Tatsuo Ohira | Author(s): J. Matsubayashi, S. Maehara, J. Maeda, K. Yoshida, M. Hagiwara, Masatoshi Kakihana, T. Okano, Naohiro Kajiwara, T. Nagao, Norihiko Ikeda
- Abstract
Loading... -
+
P3.02-013 - Prognostic Role of Circulating Tumor DNA (ctDNA) and Immune Cell Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Young Kwang Chae | Author(s): Sarita Agte, A.A. Davis, A. Pan, N.I. Simon, N.A. Mohindra, V. Villaflor
- Abstract
Loading... -
+
P3.02-014 - Amplicon-Based Next-Generation Sequencing (NGS) of Plasma Cell-Free DNA (cfDNA) for Detection of Driver and Resistance Mutations in NSCLC
09:30 - 09:30 | Presenter: Nicolas Marie Guibert | Author(s): Y. Hu, N. Feeney, E. Michael, S. Woodhouse, K. Howarth, G. Jones, C.P. Paweletz, Geoffrey R. Oxnard
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-015 - 433MHz Microwave Radiation Induces G2/M Checkpoint Arrest and Promotes Apoptosis under Hyperthermia in Non-Small Cell Lung Cancer Cells
09:30 - 09:30 | Presenter: Yanyan Zhao | Author(s): S. Zhang, Z. Wu, J. Zhang, S. Ma
- Abstract
Loading... -
+
P3.02-016 - Correlation of Programmed Cell Death Ligand-1 Messenger RNA and Protein Expression in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hyun Jung Kwon | Author(s): H. Kim, S.Y. Park, E. Park, Jin-Haeng Chung
- Abstract
Loading... -
+
P3.02-017 - Apoptosis-Related Protein in Non Small Cell Lung Cancer: Correlation of Clinicopathologic, Molecular Characteristics and Prognosis
09:30 - 09:30 | Presenter: Ping-Li Sun | Author(s): H. Gao, Jin-Haeng Chung
- Abstract
Loading... -
+
P3.02-018 - Patients Harboring ALK Rearrangement Adenocarcinoma after Acquired Resistance to Crizotinib and Transformation to SCLC: A Case Report
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): W. Wang, Chunwei Xu, Y. Zhu, X. Liao, Wu Zhuang, K. Du, Rongrong Chen, Y. Chen, Gang Chen
- Abstract
Loading... -
+
P3.02-019 - Clinical Validation of a Real Time PCR Assay for the Detection of ROS1 Fusion in Chinese Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Guanshan Zhu | Author(s): G. Huang, Q. Song
- Abstract
Loading... -
+
P3.02-020 - Comparison of Diagnostic Ability for EGFR Mutation of the Specimen Groups: Histology – Cytology – Plasma
09:30 - 09:30 | Presenter: Nguyen Son Lam | Author(s): T.D. Thanh, N.N. Vu
- Abstract
Loading... -
+
P3.02-021 - Secondary EGFR Exon 20 T790m Mutation for Therapy of Non Small Cell Lung Cancer at Phat Ngoc Thach - Ho Chi Minh City - Vietnam
09:30 - 09:30 | Presenter: Nguyen Son Lam | Author(s): N.N. Vu
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-023 - Semaphorin 7A Reduces Response to EGFR-TKI Treatment via Apoptosis in Human Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yuhei Kinehara | Author(s): I. Nagatomo, S. Koyama, A. Kumanogoh
- Abstract
Loading... -
+
P3.02-024 - Role of FBXW7 in the Maintenance of Quiescent Cancer Stem Cells Resistant to Gefitinib in EGFR Mutation-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Moulid Hidayat | Author(s): F. Takahashi, K. Tajima, Fariz Nurwidya, Aditya Wirawan, R. Kanemaru, Y. Koinuma, H. Ihara, M. Tajima, N. Matsumoto, K. Kanamori, I. Takeda, M. Haraguchi, D. Hayakawa, R. Ko, M. Kato, R. Shibayama, R. Koyama, M. Takahashi, N. Shimada, K. Takahashi
- Abstract
Loading... -
+
P3.02-025 - 65 Cases of Molecular Profiling Anaysis in Surgical Resected Pulmonary Neuroendocrine Carcinoma
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, J. Lin, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-026 - The Study of ROS1 Rearrangement in Advanced Primary Non-Small Cell Lung Cancer and Associated Metastatic Lesions
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Y. Tian, J. Zhang, L. Wang, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-027 - Lung Adenocarcinoma Patient with EGFR 19 Exon Insert Mutation: I740_K745insIPVAIK and Its Response to Icotinib: A Case Report
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Y. Chen, Meiyu Fang, Rongrong Chen, Y. Guan, X. Yi, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-028 - 276 Cases of EGFR/ALK Gene Status and Predominant Histologic Subtype in Chinese Surgically Resected Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Z. Huang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-029 - 218 Cases of EGFR/ALK Gene Status Anaysis in Chinese Lung Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-030 - Inhibitory Effects of Mitochondrial TRAP1 on Gefitinib-Resistance in Non-Small Lung Cancer Cells
09:30 - 09:30 | Presenter: Euntaik Jeong | Author(s): K. Hwang
- Abstract
Loading... -
+
P3.02-031 - Detection of Activating EGFR Mutations and Resistant T790M Mutation from cfDNA in Malignant Pleural Effusion(MPE-DNA)
09:30 - 09:30 | Presenter: Kirsty Wai Chung Lee | Author(s): O.S.H. Chan, Tony SK Mok, A.K.C. Chan, C.K. Lee, A. Fontela, T. Yung, V.W. Chan, A.C.Y. Wong, K.H. Wong, S.Y.H. Fung, W. Gai
- Abstract
Loading... -
+
P3.02-032 - Spatial Heterogeneity of EGFR and KRAS Variant Allele Frequencies Correlates with Histological Patterns of Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Steffen Dietz | Author(s): A. Harms, V. Endris, F. Eichhorn, M. Kriegsmann, R. Longuespée, A. Stenzinger, A. Warth, D. Kazdal, H. Sültmann
- Abstract
Loading... -
+
P3.02-033 - Pathological and Molecular Alterations after First and Second Generation EGFR-TKI Therapy in Patients with EGFR-Mutated Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Hironori Uruga | Author(s): Takeshi Fujii, G. Yamamoto, S. Moriguchi, Y. Takahashi, K. Ogawa, R. Murase, S. Mochizuki, S. Hanada, H. Takaya, A. Miyamoto, N. Morokawa, K. Kishi
- Abstract
Loading... -
+
P3.02-034 - Acquired Resistance to Osimertinib by CCDC6-RET Fusion in a Patient with EGFR T790M Mutant Metastatic Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Wade Thomas Iams | Author(s): Y.K. Chae
- Abstract
Loading... -
+
P3.02-035 - Mutational Signatures and Their Association with Clinicopathological Features in Lung Adenocarcinoma of Smokers
09:30 - 09:30 | Presenter: Takayuki Honda | Author(s): K. Shiraishi, H. Sakashita, K. Masai, M. Kobayashi, S. Mimaki, N. Motoi, K. Tsuchihara, K. Tsuta, K. Okubo, N. Inase, Shun-ichi Watanabe, Takashi Kohno
- Abstract
Loading... -
+
P3.02-036 - Feasibility Study to Evaluate Patterns of Metastases and Effect of Surgery on Lung Cancer Xenografts with Differing Sensitivity to EGFR TKI
09:30 - 09:30 | Presenter: Sabita Jiwnani | Author(s): C.S. Pramesh, George Karimundackal, R. Badwe, P. Choudhari
- Abstract
Loading... -
+
P3.02-038 - Diagnosis of Leptomeningeal Disease and Clonal Heterogeneity with Digital Droplet PCR (ddPCR) in EGFR Mutated NSCLC
09:30 - 09:30 | Presenter: Gareth Rivalland | Author(s): H. Do, S. Arulananda, P. Mitchell, Alexander Dobrovic, T. John
- Abstract
Loading... -
+
P3.02-039 - Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S
09:30 - 09:30 | Presenter: Atsushi Osoegawa | Author(s): T. Hashimoto, Y. Takumi, R. Kobayashi, M. Miyawaki, H. Takeuchi, Tatsuro Okamoto, K. Sugio
- Abstract
Loading... -
+
P3.02-040 - Driver Gene Detection in Chinese NSCLC Patients Using cSMART and Prognosis Analysis
09:30 - 09:30 | Presenter: Xueqin Chen | Author(s): Shaoyu Yang, Shirong Zhang, J. Huang, Shenglin Ma
- Abstract
Loading... -
+
P3.02-041 - EGFR Amplification Mediates Resistance to TAS121, A Third-Generation EGFR-TKI, in EGFR T790M-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sho Watanabe | Author(s): Yasushi Goto, N. Motoi, Takashi Kohno, J. Sato, R. Morita, S. Kanda, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P3.02-042 - DS-1205b, a Novel, Selective, Inhibitor of AXL, Delays the Onset of Resistance and Overcomes Acquired Resistance to EGFR-TKIs
09:30 - 09:30 | Presenter: Takeshi Jimbo | Author(s): T. Taira, T. Komatsu, K. Kumazawa, N. Maeda, N. Haginoya, T. Suzuki, M. Ota, Y. Totoki, C. Wada, K. Inaki, T. Isoyama, M. Uno
- Abstract
Loading... -
+
P3.02-043 - Clinical and Genetic Features in Lung Adenocarcinoma Without EGFR Mutation and ALK Rearrangement in Taiwan
09:30 - 09:30 | Presenter: Tsu-Hui Shiao | Author(s): C. Chiang, Yung-Hung Luo, H. Chao, Hsu-Ching Huang, C. Chiu
- Abstract
Loading... -
+
P3.02-044 - Diagnosis and Monitoring of EGFR Mutation Status with cfDNA in Advanced NSCLC: A Prospective Single Institution Study in Asia
09:30 - 09:30 | Presenter: Teh-Ying Chou | Author(s): H. Ho, C. Chiu, C. Tsai, P.M. Das
- Abstract
Loading... -
+
P3.02-045 - Prevalence of ALK Gene Abnormalities in Routine Diagnostics of Polish NSCLC Patients
09:30 - 09:30 | Presenter: Kamila Wojas-Krawczyk | Author(s): A. Grenda, P. Krawczyk, T. Kucharczyk, B. Jarosz, K. Reszka, J. Pankowski, A. Szlubowski, J. Buczkowski, A. Szczęsna, B. Kuźniar-Kamińska, K. Siemiątkowska, J. Kołb-Sielecki, J. Milanowski, W. Papiewski
- Abstract
Loading... -
+
P3.02-046 - EGFR-Grb2-GEP100 Complex Promoted Its Invasive and Metastatic Potential via Arf6 Pathway in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Toshi Menju | Author(s): H. Ishikawa, R. Miyata, Shigeto Nishikawa, K. Takahashi, M. Hamaji, H. Motoyama, A. Aoyama, C. Fengshi, T. Sato, M. Sonobe, H. Date
- Abstract
Loading... -
+
P3.02-047 - Testing EGFR and ALK in Large Cell Neuroendocrine Carcinoma of the Lung. Looking for Biological Features in Rare Tumors
09:30 - 09:30 | Presenter: Teresa García Manrique | Author(s): A.M. Vallejo Benítez, E. Rodriguez Zarco, A. García Escudero, D. Vicente Baz
- Abstract
Loading... -
+
P3.02-048 - Clinicopathologic Characteristics of Non-Small Cell Lung Carcinomas Habouring MET Exon 14 Skipping Mutations
09:30 - 09:30 | Presenter: Takeshi Fujii | Author(s): Hironori Uruga, N. Nakamura, T. Kohno, K. Kishi
- Abstract
Loading... -
+
P3.02-049 - The Evaluation of Circulating miRNA Expression in Plasma as the Epigenetic Marker of EGFR Mutation Status in NSCLC Patients
09:30 - 09:30 | Presenter: Mateusz Florczuk | Author(s): A. Szpechcinski, M. Komorowski, K. Duk, W. Kupis, Piotr Rudzinski, M. Bryl, T. Orlowski, Joanna Chorostowska-Wynimko
- Abstract
Loading... -
+
P3.02-050 - Mechanisms of Acquired Resistance to the ALK Inhibitor Lorlatinib in ALK-Rearranged NSCLC Cell Lines
09:30 - 09:30 | Presenter: Anne Tranberg Madsen | Author(s): Kristine Raaby Jakobsen, Christina Demuth, B.S. Sørensen
- Abstract
Loading... -
+
P3.02-051 - Low Consistency Between FGFR1 Gene Amplification and Protein Expression in Squamous Cell Lung Cancer (SQCLC)
09:30 - 09:30 | Presenter: Joanna Chorostowska-Wynimko | Author(s): M.M. Skupinska, A. Rozy, K. Siewiera, E. Szczepulska, Renata Langfort, Piotr Rudzinski, T. Orlowski, M. Wieczorek, A. Stanczak
- Abstract
Loading... -
+
P3.02-052 - Stability of EGFR Mutations in Whole Blood and Plasma in Patients with NSCLC
09:30 - 09:30 | Presenter: Johanne Andersen Højbjerg | Author(s): M.S. Clement, Anne Tranberg Madsen, T. May, P. O´donnell, P. Meldgaard, B.S. Sørensen
- Abstract
Loading... -
+
P3.02-053 - Optimization and Characterization of Assays to Identify Met Exon 14 Skipping in FFPE Embedded NSCLC Samples
09:30 - 09:30 | Presenter: Steven G. Gray | Author(s): O. O’brien, C.P. O'Brien, M. Wright, O. Geoghegan, N. Leonard, S. Nicholson, J. Wolfram, M. Joerger, A. Fabre, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P3.02-054 - Prognostic Implications of ROS1 Positivity in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Published Literature
09:30 - 09:30 | Presenter: Anchit Khanna | Author(s): S. Ryan, J. Youssef, A. Mahmood
- Abstract
Loading... -
+
P3.02-055 - Detecting ALK, ROS1 and RET Gene Translocations in Non-Small Cell Lung Cancer (NSCLC) with the NanoString Platform
09:30 - 09:30 | Presenter: Hangjun Wang | Author(s): A.F. Rijk, M.L. Aguirre, A.Y. Wang, K. Wang, Z. Dastani, J. Agulnik, V. Cohen, D. Small, C. Pepe, L. Sakr, G. Kasymjanova, L.C. Van Kempen, A. Spatz
- Abstract
Loading... -
+
P3.02-056 - EGFR Mutation Profile of NSCLC Patients Tested at the Lung Center of the Philippines
09:30 - 09:30 | Presenter: Maria Teresa Alhambra Barzaga | Author(s): Francisco III Maramara Heralde, N. Tan-Liu, S. Bernal
- Abstract
Loading... -
+
P3.02-057 - Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples
09:30 - 09:30 | Presenter: Kurtis D Davies | Author(s): D.L. Aisner, A.T. Le, J. Sheren, M. Varella-Garcia, Robert C. Doebele
- Abstract
Loading... -
+
P3.02-058 - Detection of ROS1 Rearrangements in 508 Russian Patients with Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Irina Demidova | Author(s): N. Savelov, M. Gikalo, I. Tsimafeyeu, S. Tjulandin
- Abstract
Loading... -
+
P3.02-059 - T790M and C797S as Mechanisms of Acquired Resistance to Dacomitinib in Cell Models
09:30 - 09:30 | Presenter: Yoshihisa Kobayashi | Author(s): T. Fujino, M. Nishino, S. Ohara, Y. Sesumi, M. Chiba, M. Shimoji, K. Tomizawa, T. Takemoto, Tetsuya Mitsudomi
- Abstract
Loading... -
+
P3.02-060 - EGFR Mutation Status by Three Sequencing Platforms in 704 Non-Small Cell Lung Cancer (NSCLC) Brazilian Patients
09:30 - 09:30 | Presenter: Helano Carioca Freitas | Author(s): M. Corassa, V.K. De Sa, I.D.C. Werneck, V.C.C.D. Lima, A.O. Saito, G.Z. Dal Molin, M.P. De Macedo, E.N.E. Ferreira, D.M. Carraro
- Abstract
Loading... -
+
P3.02-061 - An ALK Follow-On Companion Diagnostic Using CGP for Clinical Care of Patients with NSCLC
09:30 - 09:30 | Presenter: James Sun | Author(s): Y. Li, W. Yip, J. Luo, J. Skoletsky, C. Milbury, C. Burns, A. Tsuji, J. Truesdell, E. Peters, H. Gilbert, C. Wu, E. Schleifman, J. Noe, J. Elvin, G. Otto, D. Lipson, Jeffrey S. Ross, V.A. Miller, P.J. Stephens, M. Doherty, C. Vietz
- Abstract
Loading... -
+
P3.02-062 - An EGFR Follow-On Companion Diagnostic for Clinical Care of Patients with NSCLC
09:30 - 09:30 | Presenter: James Sun | Author(s): Y. Li, J. Luo, W. Yip, J. Skoletsky, C. Milbury, C. Burns, A. Tsuji, J. Truesdell, E. Peters, H. Gilbert, C. Wu, E. Schleifman, C. Barrett, K.S. Thress, S. Jenkins, J. Elvin, G. Otto, D. Lipson, Jeffrey S. Ross, V.A. Miller, P.J. Stephens, M. Doherty, C. Vietz
- Abstract
Loading... -
+
P3.02-063 - EGFR Exon 20 Insertions in Lung Adenocarcinomas: Molecular and Clinicopathologic Characteristics Among Hispanics (Geno1.2-CLICaP)
09:30 - 09:30 | Presenter: Oscar Arrieta | Author(s): Andrés F. Cardona, G. Oblitas, L. Rojas, Z.L. Zatarain-Barron, L. Corrales, Claudio Martin, J. Rodriguez, P. Archila, Alejandro Ruiz-Patiño, M.A. Pérez, L. González, L. Chirinos, H. Carranza, C. Vargas, Rafael Rosell
- Abstract
Loading... -
+
P3.02-064 - Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-066 - Wild-Type KRAS Mediates Growth Inhibition and Resistance to MEK Inhibitors through Dimerization with Mutant KRAS in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Chiara Ambrogio | Author(s): J. Kohler, Z. Zhou, H. Wang, R. Paranal, M. Capelletti, C. Caffarra, S. Li, Q. Lv, S. Gondi, J.C. Hunter, R. Chiarle, D. Santamaría, K.D. Westover, Pasi A Jänne
- Abstract
Loading... -
+
P3.02-067 - Lung Cancer with Concurrent EGFR Mutation and ROS1 Rearrangement: A Case Report
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Y. Zhu, Chunwei Xu, W. Wang, X. Liao, K. Du, Wu Zhuang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-069 - 58 Cases of EGFR/ALK Gene Status Anaysis in Pulmonary Sarcomatoid Carcinoma
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Y. Huang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-070 - Investigation of Whether HIF-1α Inhibitors Can Increase EGFR-TKI Effect for Non-Small Cell Lung Cancer Cell Lines
09:30 - 09:30 | Presenter: Yung-Hung Luo | Author(s): H. Yang, S. Hong, J. Whang-Peng, Y. Chen
- Abstract
Loading... -
+
P3.02-071 - Statins May Improve the Prognosis of Patients with Lung Adenocarcinoma by Suppressing Mutant p53-Induced EMT
09:30 - 09:30 | Presenter: Shigeto Nishikawa | Author(s): Toshi Menju, T. Soawa, K. Takahashi, R. Miyata, H. Ishikawa, M. Hamaji, H. Motoyama, A. Aoyama, T. Sato, C. Fengshi, M. Sonobe, H. Date
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-074 - Podoplanin-Positive CAF Is Associated with a Higher Number of Single Nucleotide Variants in Cancer Cells in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Shoko Nakasone | Author(s): S. Mimaki, Tomohiro Ichikawa, T. Sakai, S. Okada, K. Sekihara, T. Miyoshi, K. Tane, Keiju Aokage, Koichi Goto, K. Tsuchihara, M. Tsuboi, G. Ishii
- Abstract
Loading... -
+
P3.02-075 - Molecular Disorders of the Genes of Intracellular Signal Pathways in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Anna Shchayuk | Author(s): M. Shapetska, A. Mikhalenka, N. Chebotaryova, E. Krupnova
- Abstract
Loading... -
+
P3.02-076 - Glutaminase Inhibitor CB-839 Radiosensitizes KRAS-Mutant Lung Cancer Cells in a LKB1- and KEAP1/NRF2-Pathway Dependent Manner
09:30 - 09:30 | Presenter: Piyada Sitthideatphaiboon | Author(s): Q. Xiao, U. Giri, John V Heymach
- Abstract
Loading... -
+
P3.02-077 - Platin Sensitivity and ATM-Deficiency in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: D. Gwyn Bebb | Author(s): J. Moore, L.F. Petersen, A.A. Elegbede
- Abstract
Loading... -
+
P3.02-078 - Establishing Malignant Pleural Mesothelioma Primary Cell Lines Using the 3D Spheroid Method Produces a Model with Better Tumour Architecture
09:30 - 09:30 | Presenter: Yuen Yee Cheng | Author(s): K.H. Sarun, K. Lee, C.J. Clark, N.C. Cheng, Nico Van Zandwijk, Sonja Klebe, Glen Reid
- Abstract
Loading... -
+
P3.02-079 - A 3D Spheroid Culture Represents an Improved in Vitro Model of Malignant Plural Mesothelioma (MPM)
09:30 - 09:30 | Presenter: Yuen Yee Cheng | Author(s): Y. Wang, Nico Van Zandwijk, Glen Reid
- Abstract
Loading... -
+
P3.02-080 - DNMT3A Defines a Unique Molecular Class of Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Y. Zhu, W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P3.02-081 - Nutritional Status Assessment in Treatment Naïve Patients with Lung Cancer
09:30 - 09:30 | Presenter: Sabita Jiwnani | Author(s): P. Ranganathan, P. Patil, George Karimundackal, C.S. Pramesh
- Abstract
Loading... -
+
P3.02-082 - High Mobility Group Box 1 Antagonist Limits Metastatic Seeding in the Lungs via Reduction of Cell-Cel Adhesion
09:30 - 09:30 | Presenter: Adi Karsch-Bluman | Author(s): B. Amoyav, N. Friedman, H. Shoval, E. Ella, O. Wald, O. Benny
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-084 - FGF9-FGFR Pathway Induce Neuroendocrine Differentiation in Lung Epithelial Cells
09:30 - 09:30 | Presenter: Kota Ishioka | Author(s): H. Yasuda, K. Soejima, D. Arai, O. Keiko, J. Hamamoto, M. Ozaki, K. Masuzawa, I. Kawada, K. Naoki, K. Emoto, Y. Hayashi, H. Watanabe, H. Ahmed, T. Betsuyaku
- Abstract
Loading... -
+
P3.02-085 - Sphingosine Kinase 1 (SPHK1) Promotes Proliferation and Survival in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Nozomu Motono | Author(s): Y. Ueda, A. Funasaki, T. Matsui, R. Maeda, A. Sekimura, K. Usuda, H. Uramoto
- Abstract
Loading... -
+
P3.02-086 - MGA Suppresses the MYC Pathway in Lung Adeocarcinoma
09:30 - 09:30 | Presenter: Paula Llabata | Author(s): Y. Mitsuishi, P.S. Choi, M. Torres-Diz, Diana Cai, X. Zhang, Montse Sanchez-Cespedes, Matthew Meyerson
- Abstract
Loading... -
+
P3.02-087 - Long Noncoding RNA FOXF1-AS1 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
09:30 - 09:30 | Presenter: Yongsheng Wang | Author(s): L. Miao
- Abstract
Loading... -
+
P3.02-088 - Enhanced Glycolysis Is Critical for Maintaining Inactivation of JNK and Stability of EGFR Leading to the Survival of EGFR-Mutant Lung Cancer Cells
09:30 - 09:30 | Presenter: Jae Cheol Lee | Author(s): J.K. Rho, J. Son, C. Choi
- Abstract
Loading... -
+
P3.02-089 - Establishment of Highly Metastatic Lung Cancer Cell Sublines in Long-term Three-dimensional Low Attachment Cultures
09:30 - 09:30 | Presenter: Tomoyuki Nakano | Author(s): Y. Kanai, Y. Amano, Taichiro Yoshimoto, Daisuke Matsubara, T. Shibano, S. Endo, Toshiro Niki
- Abstract
Loading... -
+
P3.02-090 - Hypoxia-Induced Modifications of the Small Non-Coding RNA Transcriptome Delineates Risk of Recurrence in Early-Stage Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Victor D Martinez | Author(s): Erin Anne Marshall, N. Firmino, Brenda C. Minatel, K.L. Bennewith, W.L. Lam
- Abstract
Loading... -
+
P3.02-091 - Concurrent Aberrations in G2/M-Phase Transcriptional Programs and Genomic Gatekeepers Highlight Lung Cancer Predisposition in COPD Patients
09:30 - 09:30 | Presenter: Erin Anne Marshall | Author(s): E.A. Vucic, Victor D Martinez, R.T. Ng, Stephen Lam, W.L. Lam
- Abstract
Loading... -
+
P3.02-092 - CD151-Integrin-C-Kit Axis Plays an Important Role in the Pathogenesis of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Zeyi Liu
- Abstract
Loading... -
+
P3.02-093 - Knockdown of BRM Causes Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cell Line H1975
09:30 - 09:30 | Presenter: Daisuke Matsubara | Author(s): M. Takahashi, Taichiro Yoshimoto, Toshiro Niki
- Abstract
Loading... -
+
P3.02-094 - Identification of Oncofetal piRNAs in Lung
09:30 - 09:30 | Presenter: Brenda C. Minatel | Author(s): Victor D Martinez, D.D. Becker-Santos, Erin Anne Marshall, K.W. Ng, Adam Patrick Sage, C. Anderson, W.P. Robinson, I. Jurisica, W.L. Lam
- Abstract
Loading... -
+
P3.02-095 - Basic Transcription Factor 3 Is Involved in Lung Cancer Growth and Progression
09:30 - 09:30 | Presenter: Xiongfei Li | Author(s): S. Xu, Renwang Liu, T. Shi, Y. Li, H. Liu, J. Chen
- Abstract
Loading... -
+
P3.02-096 - The Interaction Between Mast Cells and Lung Cancer Cells Through Extracellular Vesicles
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): Y. Gorzalczany, L.C. Roisman, M. Ilouze, R. Shemesh, R. Sagi-Eisenberg, Nir Peled
- Abstract
Loading... -
+
P3.02-097 - Clinicopathological Features and Genetic Landscape of Pulmonary Large Cell Carcinoma under 2015 WHO Classification of NSCLC
09:30 - 09:30 | Presenter: Renwang Liu | Author(s): T. Shi, Xiongfei Li, S. Wei, G. Chen, J. Chen, S. Xu
- Abstract
Loading... -
+
P3.02-097a - Metabolic Biomarkers in Serum for the Early Diagnosis of Lung Cancer: First Results from the Cancer-Biomarkers in HUNT Initiative
09:30 - 09:30 | Presenter: Oluf Dimitri Røe | Author(s): R. Mjelle, H.F. Kvitvang, I. Tsamardinos, M. Markaki, O.T.D. Nguyen, V. Lagani
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-097c - Detection of the EGFR P.(T790M) Mutation by Different Methods: A Small Comparison Case Study
09:30 - 09:30 | Presenter: Hangjun Wang | Author(s): A. Spatz, M.L. Aguirre, J. Agulnik, V. Cohen, D. Small, C. Pepe, L. Sakr, G. Kasymjanova, A.Y. Wang, S. Owen, Ming Sound Tsao, L.V. Kempen
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.02-097e - Prognostic Importance of Tumor Spread Through Air Spaces in Lymph Node Negative Operated Adenocarcinoma Lung Cancers
09:30 - 09:30 | Presenter: F.S. Biricik | Author(s): Ş. Dilege, S. Tanju, S. Erus, P. Bulutay, Nil Molinas Mandel
- Abstract
Loading... -
+
P3.02-097f - Rare Actionable Mutations in a Lung Adenocarcinoma Cohort in Brazil
09:30 - 09:30 | Presenter: C.G. Ferreira | Author(s): M. Zalis, M. Reis, L. Schluckebier, T.C. Montella
- Abstract
Loading... -
+
P3.02-097g - LRIG1 and LMO7 Are Interacting Proteins with Clinical Significance in NSCLC
09:30 - 09:30 | Presenter: Samuel Kvarnbrink | Author(s): T. Karlsson, C. Holmlund, J. Botling, Patrick Micke, M. Johansson, H. Hedman
- Abstract
Loading... -
+
P3.02-097h - Mutational Analysis of Multiple Lung Cancers: Discrimination between Primary and Metastatic Lung Cancers by Genomic Profile
09:30 - 09:30 | Presenter: Taichiro Goto
- Abstract
Loading... -
+
P3.02-097i - Neutrophil to Lymphocyte Ratio may be a Prognostic Factor in Advanced Stage Lung Cancer Patients
09:30 - 09:30 | Presenter: Bülent Karagöz | Author(s): Metin Guden, S. Celik, T. Hancilar
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-001 - Immunotherapy Toxicity: Are General Practitioner Satisfied About Information Transmitted? A Retrospective Survey
09:30 - 09:30 | Presenter: Radj Gervais | Author(s): L. Hamel Sénécal, F. Divanon, N. Leiber, C. Dubos Arvis, P. Dô
- Abstract
Loading... -
+
P3.03-002 - Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
09:30 - 09:30 | Presenter: Tadaaki Yamada | Author(s): J.M. Amann, A. Tanimoto, Hirokazu Taniguchi, T. Shukuya, S. Yano, K. Takayama, David P Carbone
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.03-006 - Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): K. Li, Q. Wang, Y.Z. Zhao, L. Zhang, J. Shi, Z. Wang, Ying Cheng, J. He, S. Yuankai, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, B. Li
- Abstract
Loading... -
+
P3.03-007 - LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor
09:30 - 09:30 | Presenter: Mark G Kris | Author(s): D.L. Aisner, L.M. Sholl, L.D. Berry, M. Rossi, H. Chen, J. Fujimoto, Andre L. Moreira, Suresh S Ramalingam, L.C. Villaruz, G. Otterson, E. Haura, K. Politi, B. Glisson, J. Cetnar, Edward Brian Garon, Joan Schiller, S.N. Waqar, Lecia V Sequist, Julie R Brahmer, Yu Shyr, K. Kugler, Ignacio I. Wistuba, B.E. Johnson, J. Minna, Paul A. Bunn, Jr., D.J. Kwiatkowski
- Abstract
Loading... -
+
P3.03-008 - Organoid Cultures of Lung Squamous Cell Carcinoma for Drug Screening
09:30 - 09:30 | Presenter: Ruoshi Shi | Author(s): N. Radulovich, M. Cabanero, M. Pintille, V. Raghavan, R. Quevedo, L. Tamblyn, C. Ng, V. Stambolic, T. Pugh, N. Moghal, Ming Sound Tsao
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.03-010 - Identification of Mechanisms of Drug Resistance in RET-Rearranged Lung Cancer
09:30 - 09:30 | Presenter: Takashi Nakaoku | Author(s): Takashi Kohno
- Abstract
Loading... -
+
P3.03-011 - A Report of BRAF V600E Positive Lung Adenocarcinoma Patient Who Respond Well to Pemetrexed
09:30 - 09:30 | Presenter: Yoshiko Nakagawa | Author(s): Y. Nakanishi, I. Tsujino, T. Shimizu, N. Takahashi, Y. Kusumi, S. Masuda, S. Hashimoto
- Abstract
Loading... -
+
P3.03-012 - The Relationship between Efficacy of Wee1 Inhibitor AZD1775 and Mutational Status of TP53 in KRAS-Mutant Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Bo Mi Ku | Author(s): Y. Bae, J. Koh, Jong-Mu Sun, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P3.03-013 - Identification of Proteasomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer through a Pooled shRNA Screen
09:30 - 09:30 | Presenter: Mitsuo Sato | Author(s): T. Kakumu, D. Goto, T. Kato, N. Yogo, T. Hase, M. Morise, T. Fukui, K. Yokoi, Yoshitaka Sekido, L. Girard, J. Minna, Lauren Byers, John V Heymach, K. Coombes, M. Kondo, Y. Hasegawa
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.03-015 - ROS-1 Rearranged Non Small Cell Lung Cancer and Crizotinib: An Indian Experience
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): Vijay Patil, A. Joshi, V. Noronha, C. Mv, R. Kaushal, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading... -
+
P3.03-016 - Morphometric Genotyping Identifies Lung Cancer Cells Harboring Target Mutations; Cell-CT® Platform Detects Gene Abnormalities
09:30 - 09:30 | Presenter: Alan Nelson | Author(s): Michael Meyer, Daniel J Sussman, R. Katdare, C. Presley, F. Lakers, C. Hamilton, D. Wilbur, R. Mastrangelo, M. Doherty
- Abstract
Loading... -
+
P3.03-017 - Blood Samples NGS for Baseline Molecular Signature of Anotinib Treated Advanced NSCLC Patients in ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han | Author(s): Y.Z. Zhao, K. Li, J. Wang, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.03-019 - Activity of PARP Inhibitor in NSCLC with Germline and Somatic Mutation and in Silico Chemotherapy Lethality
09:30 - 09:30 | Presenter: Carmelia Maria Noia Barreto | Author(s): Pedro Aguiar Jr, F.S. Silverio, M.S. Yaksic, M.F.G. Manfrivato, L.M. Naraki, E.C. Souza, P. Tamura, K. Kobayashi, L.L. Zapata, T.C.D. Padua, F.M. Silva, M.A. Spada, R. Parmigiani, Nise Yamaguchi
- Abstract
Loading... -
+
P3.03-020 - Unique Molecular Profile of NSCLC in Thai Population
09:30 - 09:30 | Presenter: Narumol Trachu | Author(s): P. Incharoen, A. Jinawat, A. Charoenyingwattana, O. Trachoo, I. Senson, W. Pairoj, P. Janchompoo, C. Srichunrusami, S. Detarkom, S. Lukrak, E. Sirachainan, T. Sirisinha Dejthevaporn, R. Panvichien, W. Chantratita, P. Tienchainaanda, M. Ngodnbamthaweesuk, N. Prasongsook, S. Techasurungkul, N. Iemwimangsa, W. Klaisuban, Thanyanan Reungwetwattana
- Abstract
Loading... -
+
P3.03-021 - In Vitro Pharmacogenomic Platform with a High-Purity Patient-Derived Cell Model
09:30 - 09:30 | Presenter: Hyun Chang | Author(s): S. Kim, H. Kim, Hye Ryun Kim, Byoung Chul Cho
- Abstract
Loading... -
+
P3.03-022 - Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement but Better Survival
09:30 - 09:30 | Presenter: Nir Peled | Author(s): A.M. Suidan, M. Ilouze
- Abstract
Loading... -
+
P3.03-023 - Nintedanib Selectively Inhibits the Activation and Tumor-Promoting Effects of Fibroblasts from Lung Adenocarcinoma Patients
09:30 - 09:30 | Presenter: Noemi Reguart | Author(s): M. Gabasa, R. Ikemori, F. Hilberg, J. Alcaraz
- Abstract
Loading... -
+
P3.03-024 - Real-Life Experience and Clinical Characterization of BRAF V600E Mutation in Austrian NSCLC Patients
09:30 - 09:30 | Presenter: Maximilian Johannes Hochmair | Author(s): S. Schwab, U. Setinek, D. Krenbek, S.B. Watzka, S. Gasser, F. Huemer, I. Kapfhammer, H. Fabikan, E. Hauptmann-Repitz, O. Burghuber
- Abstract
Loading... -
+
P3.03-025 - Tumor Biomarkers for the Routine Care of Advanced Non-Small-Cell Lung Cancer: A Decade of Experience in Implementing Predictive Genomic Events
09:30 - 09:30 | Presenter: Paul Andrew Vanderlaan | Author(s): D. Rangachari, X. Le, A. Majid, M.S. Parikh, S.P. Gangadharan, M.S. Kent, M. Huberman, S.S. Kobayashi, D.B. Costa
- Abstract
Loading... -
+
P3.03-026 - Cell-CT® Differential Detection of Dysplastic Bronchial Epithelial Cells from Patient Explants
09:30 - 09:30 | Presenter: Daniel J Sussman | Author(s): Michael Meyer, R. Katdare, C. Presley, T. Bell, J. Reyna, F. Lakers, C. Hamilton, Javier J. Zulueta, Y.E. Miller, M. Ghosh, Alan Nelson
- Abstract
Loading... -
+
P3.03-027 - LKB1 Loss Is Associated with Resistance to Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer Mouse Models
09:30 - 09:30 | Presenter: Irene Guijarro | Author(s): A. Poteete, Y. Fan, S. Cho, P. Tong, E. Roarty, M. Nilsson, J. Rodriguez-Canales, B. Mino, E.R. Parra Cuentas, Ignacio I. Wistuba, J. Wang, John V Heymach
- Abstract
Loading... -
+
P3.03-028 - WINTHER – a Study of Cancer Therapy Based on Tumor and Normal-Matched Biopsies – the Sheba Medical Center Lung Cancer Experience
09:30 - 09:30 | Presenter: Amir Onn | Author(s): T. Sella, A. Ackerstein, S. Halperin, G. Hout-Siloni, S. Lieberman, I. Barshack, H. Nechushatan, R. Berger, J. Bar
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.03-031a - The IGFBP-3 Methylation Status Could Define a New Alternative Schedule for NSCLC Treatment
09:30 - 09:30 | Presenter: Javier De Castro Carpeño | Author(s): J. Jimenez Hernandez, O. Pernia Arias, R. Perona, L. Pintado Berninches, B. Fernandez-Varas, I. Ibáñez De Cáceres
- Abstract
No abstract available for this presentation
-
+
P3.03-031b - Results of a Phase II Study of Stereotactic Radiosurgery Followed by Erlotinib for Patients with EGFR Mutation and Progression in 5 or Fewer Sites
09:30 - 09:30 | Presenter: Jared Weiss | Author(s): B.D. Kavanagh, A.M. Deal, T. Zagar, L.B. Marks, Thomas E. Stinchcombe, Hossein Borghaei, Howard L West, D.E. Morris, L.C. Villaruz, N. Pennell
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-001 - Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
09:30 - 09:30 | Presenter: Dawei Yang | Author(s): C. Bai, Jie Hu, R. Yung, N. Wang
- Abstract
Loading... -
+
P3.04-002 - A Randomized Phase II Study of Carboplatin plus Nab-Paclitaxel with or Without Nintedanib for NSCLC with IPF (J-SONIC): Trial in Progress
09:30 - 09:30 | Presenter: Kohei Otsubo | Author(s): J. Kishimoto, Hirotsugu Kenmotsu, Y. Minegishi, Eiki Ichihara, A. Shiraki, Terufumi Kato, Shinji Atagi, Hidehito Horinouchi, M. Ando, Y. Kondoh, Masahiko Kusumoto, K. Ichikado, Nobuyuki Yamamoto, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading... -
+
P3.04-003 - Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC
09:30 - 09:30 | Presenter: Helen J Ross | Author(s): D. Kozono, J. Urbanic, T. Williams, C. Dufrane, I. Bara, M. Gandhi, K. Schulze, J..M. Brockman, X. Wang, Everett E Vokes, Thomas E. Stinchcombe
- Abstract
Loading... -
+
P3.04-004 - Treatment Rationale and Study Design for the TAKUMI Trial
09:30 - 09:30 | Presenter: Kentaro Tanaka | Author(s): H. Asahina, J. Kishimoto, K. Sugio, Yoichi Nakanishi, S. Oizumi, Isamu Okamoto
- Abstract
Loading... -
+
P3.04-005 - PD-L1 and Other Immuno-Markers Influenced by Osimertinib Treatment in Advanced Non-Small Cell Lung Cancer Patients (ATHENE Study)
09:30 - 09:30 | Presenter: Shun Lu | Author(s): Yongfeng Yu, H. Jian
- Abstract
Loading... -
+
P3.04-006 - SYSTEMS-2: Randomised Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Miranda Jane Ashton | Author(s): N. O'Rourke, N. Macleod, S. Smith, R. Valentine, B. Laird, S. Sheridan, L. Alexander, A. Chalmers
- Abstract
Loading... -
+
P3.04-007 - A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
09:30 - 09:30 | Presenter: Yutao Liu | Author(s): X. Hu, J. Jiang, S. Zhou, P. Liu, Junling Li, Y. Wang, X. Hao, Yuankai Shi
- Abstract
Loading... -
+
P3.04-008 - A Phase 1b/2 Study of Atezolizumab With or Without Daratumumab in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Rathi N Pillai | Author(s): Suresh S Ramalingam, Luis Paz-Ares, M. Thayu, P. Watson, Martin Reck
- Abstract
Loading... -
+
P3.04-009 - Stereotactic Body Radiotherapy to All Sites of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Combined with Durvalumab and Tremelimumab
09:30 - 09:30 | Presenter: Ticiana A. Leal | Author(s): M. Bassetti, J. Lang, Z. Morris, B. Morris, J. Eickhoff, A. Traynor, T. Campbell, K. Matkowskyj, A. Baschnagel
- Abstract
Loading... -
+
P3.04-010 - Validation of a ctDNA Methylation Assay to Differentiate Benign and Malignant Pulmonary Nodules: A Chinese Nationwide Multi-Center Study
09:30 - 09:30 | Presenter: Wenhua Liang | Author(s): J. He, X. Zhi, F. Yu, C. Cheng, Z. Wang, K. Cai, G. Jiang, C. Chen, Q. Luo, L. Chen, J. Hu, L. Liu, X. Li, Q. Wu, S. Xu, J. Liu, Y. Yang, H. Tian, X. Cai, J. Fan, O.B.O. Chinese Clincal Trial Consortium (cctc)
- Abstract
Loading... -
+
P3.04-011 - A Prospective Study to Optimize the Extent of Pulmonary Resection According to Decision-Making Algorithm in cStage IA NSCLC
09:30 - 09:30 | Presenter: Hong Kwan Kim | Author(s): H.Y. Lee, Yoon-La Choi, Hojoong Kim, K. Lee, Sumin Shin, Jong Ho Cho, Y.S. Choi, Jhingook Kim, J.I. Zo, Y.M. Shim
- Abstract
Loading... -
+
P3.04-012 - Phase 1 Study of the AXL Inhibitor DS-1205c in Combination with Osimertinib in Subjects with Metastatic or Unresectable EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Pasi A Jänne | Author(s): H.A. Yu, M. Vigliotti, N. Shipitofsky, J. Li, J. McGill, C. Yu
- Abstract
Loading... -
+
P3.04-013 - Phase 1 Study of the Anti-HER3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Pasi A Jänne | Author(s): H.A. Yu, M. Vigliotti, N. Shipitofsky, J. Singh, F. Guevara, C. Yu
- Abstract
Loading... -
+
P3.04-013a - CONFIRM: A Phase III Randomized Trial to Evaluate the Efficacy of Nivolumab versus Placebo in Relapsed Mesothelioma
09:30 - 09:30 | Presenter: Dean A Fennell | Author(s): E.V. Kirkpatrick, K. Cozens, S. Danson, Gerard G Hanna, J.F. Lester, J. Lord, M. Nye, C. Ottensmeier, Peter Szlosarek, N. Steele, M. Kalevras, T. Maishman, G. Griffiths
- Abstract
Loading... -
+
P3.04-013b - TTFields and Radiosurgery for 1-10 Brain Metastases from NSCLC: The Phase 3 METIS Study
09:30 - 09:30 | Presenter: U. Weinberg | Author(s): Minesh P Mehta, V. Gondi, Manmeet Ahluwalia,, P.D. Brown
- Abstract
Loading...
-
+
P3.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
-
+
P3.05-001 - Breath Analysis for Early Detection of Lung Cancer: The LuCID Study
09:30 - 09:30 | Presenter: Marc Phillipe Van Der Schee | Author(s): J. Dickson, M. Ruparel, Sam M Janes, S. Dragonieri, L. Fuller, S. Grundy, David Raymond Baldwin, P. Crosbie, A. Prasad, M. Haris, A. Barlow, L. Calvert, A. Wight, J. Bennett, M. Gaga, S. Chee, V. Conteh, Martin Ledson, C. Hodkinson, J. Boschmans, R. Smith, R. Parris, D. Apthorp, S. Kitchen, M. Allsworth, B. Boyle, Robert Campbell Rintoul
- Abstract
Loading... -
+
P3.05-002 - The Effect of Nodule Size on the Sensitivity of the LuCED® Test for Lung Cancer
09:30 - 09:30 | Presenter: Michael Meyer | Author(s): R. Katdare, C. Presley, D. Wilbur, Javier J. Zulueta, Alan Nelson
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.05-004 - The Impact of EGFR Mutations on Incidence and Survival of NSCLC Patients with Brain Metastasis: a Single Center Retrospective Study
09:30 - 09:30 | Presenter: Wei-Yuan Chang | Author(s): S. Yang, Yi-Lin Wu, Chien-Chung Lin
- Abstract
Loading... -
+
P3.05-005 - Hypermethylation of the RASSF1A and SOX1 Genes in Tumor DNA Predicts Unfavorable Overall Survival in Surgically Resected NSCLC Patients
09:30 - 09:30 | Presenter: Milica Kontic | Author(s): D. Jovanovic, H. Nelson, S. Ognjanovic
- Abstract
Loading... -
+
P3.05-006 - Integrated Genomic Analysis to Assess the Molecular Signature of Japanese Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Mitsuhiro Isaka | Author(s): M. Serizawa, T. Nagashima, S. Ohnami, K. Ohshima, K. Urakami, Hideaki Kojima, S. Takahashi, A. Ono, T. Sugino, T. Takahashi, Y. Ohde, M. Kusuhara, K. Yamaguchi
- Abstract
Loading... -
+
P3.05-007 - Potential of CYFRA 21-1 and CEA to Predict Adjuvant Chemotherapy Benefit in Early-Stage Squamous Cell Lung Cancer
09:30 - 09:30 | Presenter: Achim Escherich | Author(s): T. Muley, V. Rolny, Y. He, B. Wehnl, A. Warth, C. Stolp, M.A. Schneider, H. Dienemann, M. Meister, F.J. Herth, F. Dayyani
- Abstract
Loading... -
+
P3.05-008 - Potential of CYFRA 21-1 and HE4 to Detect Recurrence in Patients with Early-Stage Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Achim Escherich | Author(s): T. Muley, Y. He, V. Rolny, B. Wehnl, A. Warth, C. Stolp, M.A. Schneider, H. Dienemann, M. Meister, F.J. Herth, F. Dayyani
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P3.05-010 - NOTCH 1 and NOTCH 3 Expressions for Early Stage of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Eun Kyung Cho | Author(s): S.Y. Ha, J. Lee, S.Y. Kyung, S.M. Kang, H.K. Ahn, Y.J. Kim, J.W. Park, S.H. Jung
- Abstract
Loading... -
+
P3.05-012 - Clinicopathological Determinants of Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Jong Ho Cho | Author(s): Hong Kwan Kim, S. Lee, J.Y. Lee, Y.S. Choi, J.I. Zo, Y.M. Shim, Jhingook Kim, S. Mortimer, J. Odegaard
- Abstract
Loading... -
+
P3.05-012a - Inference of Gene Expressions Associated with Recurrence of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Seo Ree Kim | Author(s): J.H. Lee, J.H. Hong
- Abstract
Loading...
-
+
P3.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
P3.06-001 - Tobacco Use, Awareness and Oral Health among Kanchipuram Silk Weavers, Tamil Nadu, India
09:30 - 09:30 | Presenter: Delfin Lovelina Francis
- Abstract
Loading... -
+
P3.06-002 - Tobacco Use, Awareness and Oral Health Status among Seafarers in Voc Port, Tuticorin, Tamilnadu, India
09:30 - 09:30 | Presenter: Delfin Lovelina Francis
- Abstract
Loading... -
+
P3.06-003 - What Do the Children Think about Smoking and How Are They Helped in Prevention?
09:30 - 09:30 | Presenter: Domenico Galetta | Author(s): D. Bafunno, C. Biglia, A. Catino, F. Ferraresi, V. Lapadula, S. Leo, A.F. Logroscino, A. Miccianza, A. Misino, E.S. Montagna, M.V. Pacchiana, P. Petrillo, P. Pizzutilo, S.G. Rapetti, D. Ricci, Silvia Novello
- Abstract
Loading... -
+
P3.06-004 - Role Models “a Tool for Effective Tobacco Control Campaign”
09:30 - 09:30 | Presenter: Seye O Omiyefa
- Abstract
Loading... -
+
P3.06-005 - Informational Needs on Smoking Cessation of Cancer Patients
09:30 - 09:30 | Presenter: Meredith Elana Giuliani | Author(s): L. Eng, T. Papadakos, N.K. Quartey, N. Abdelmutti, G. Liu, J. Papadakos
- Abstract
Loading... -
+
P3.06-006 - The Government Willingness to Legislate Tobacco Control and Changes on Individual Behavior in Brazil
09:30 - 09:30 | Presenter: Ana Paula Leal Teixeira | Author(s): T.M. Cavalcante
- Abstract
Loading... -
+
P3.06-007 - Level of Awareness of Various Aspects of Lung Cancer Among College Students in India: Impact of Cancer Awareness Programes
09:30 - 09:30 | Presenter: Abhishek Shankar | Author(s): S. Roy, G.K. Rath
- Abstract
Loading... -
+
P3.06-008 - Lung Cancer Pathways: A Five-Year Program to Reduce Impact Through Epidemiological Modelling and Investment in Prioritized Interventions
09:30 - 09:30 | Presenter: Nicole Marion Rankin | Author(s): M. Weber, Q. Luo, S. Wade, S. Hughes, Kwun M Fong, K. Canfell
- Abstract
Loading... -
+
P3.06-009 - How Does Screening for the Early Detection of Lung Cancer Facilitate Smoking Cessation? A Qualitative Study of Screened Smokers
09:30 - 09:30 | Presenter: Ben Young | Author(s): K. Vedhara, D. Kendrick, J. Robertson, R. Das Nair
- Abstract
Loading... -
+
P3.06-009a - Lung Cancer in the Elderly - Histology, Localization and Gender Distribution in North Romania
09:30 - 09:30 | Presenter: L. Miron | Author(s): T. Alexa-Stratulat, M.I. Paduraru, V. Afrasanie, A. Hordila, A. Luca
- Abstract
Loading...